aTyr Pharma | LIFE - Beneficio Operativo

Precio De Mercado
0.81
Cambio Diario
-0.02 -2.37%
Mensual
-20.00%
Anual
-78.04%
Q1 Expectativa
0.78




Beneficio Operativo Cambio Fecha
Alterity Therapeutics Limited AUD -7.77M 2.99M 2023-06
Ardelyx USD 5.1M 431K 2025-12
aTyr Pharma USD 24.47M 51.21M 2025-12
Biogen USD 659.6M 192.2M 2025-09
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Cipla INR 9.77B 6.21B 2025-12
Clal Biotechnology ILS -1.74M 7.46M 2022-12
Compugen USD 56.04M 63.93M 2025-12
CSL USD 2.64B 1.97B 2025-12
Curis USD -12.51M 40K 2024-06
Galapagos EUR 780.56M 822.23M 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Grifols EUR 320.55M 91.01M 2025-12
Novartis USD 4.06B 437M 2025-12
Roche Holding CHF 9.56B 3.8B 2025-12
United Therapeutics USD -14.6M 403.9M 2025-12
Xoma USD -15.64M 5.56M 2024-09